Back to Top
Go Back
Journal Photo for The Journal of Clinical Psychiatry
Peer reviewed only Open Access

The Journal of Clinical Psychiatry (JCP)

Publisher : Physicians Postgraduate Press, Inc
Psychosis Psychiatry Women’s Mental Health
e-ISSN 1555-2101
p-ISSN 0160-6689
Issue Frequency Bi-Monthly
Impact Factor 5.906
Est. Year 1978
Mobile 9012732711
Country United States
Language English
APC YES
Impact Factor Assignee Google Scholar
Email JCPembargo@psychiatrist.com

Journal Descriptions

The Journal of Clinical Psychiatry is a peer-reviewed medical journal that covers clinical psychiatry, especially depression, bipolar disorder, schizophrenia, anxiety, addiction, and attention-deficit/hyperactivity disorder, as well as several other mental disorders. It is the official journal of the American Society for Clinical Psychopharmacology and was established in 1940 as Diseases of the Nervous System, before obtaining its current name in 1979. Most subscribers receive the journal free of charge if they are designated as psychiatric clinicians in provider databases such as the American Medical Association's masterfile. The journal occasionally publishes sponsored supplements. Although these supplements may be perceived as more biased by commercial interests, and are subjected to a different peer review process than articles in the journal proper, they nevertheless have a comparable number of citations.

The Journal of Clinical Psychiatry (JCP) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Psychosis, Psychiatry, Women’s Mental Health, Psychiatrists, Psychotherapy, behavioral health, neuropsychiatric disorders , Online or Print , Bi-Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0160-6689, E-ISSN: 1555-2101, Established: 1978, Impact Factor: 5.906
  • Does Not Provide Crossref DOI
  • Indexed in: Scopus, WoS

  • Not indexed in DOAJ, PubMed, UGC CARE

Indexing

Publications of JCP

Peer Briken August, 2003
Background: In addition to psychotherapy, pharmacotherapy is an important treatment option for paraphilias, especially in sexual offenders. Cyproterone acetate (CPA) and medroxyprogesterone...
Peer Briken October, 2004
Sir: In 1998, Rösler and Witztum1 published the first systematic study of antihormonal treatment of paraphilias with luteinizing hormone–releasing hormone (LHRH) agonists. Since the publi...